Skip to main content
Premium Trial:

Request an Annual Quote

Response Biomedical Completes Share Consolidation

NEW YORK (GenomeWeb News) – Response Biomedical has completed a 20-for-one share consolidation, the Vancouver, British Columbia-based firm said yesterday after the close of the market.

The diagnostics firm said that it expects its post-consolidation common shares will begin trading on the Toronto Stock Exchange and the OTC Bulletin Board in the US on Sept. 26. It announced the share consolidation last month.

The shares were trading at $.08 on the OTC Bulletin Board, with no shares trading hands, early Tuesday afternoon.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.